Medicare Enrolled

Dr. Shadan Mansoor, M.D.

Hematology & Oncology · Burleson, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
11805 SOUTH FWY STE 201, Burleson, TX 76028
8175515312
In practice since 2006 (19 years)
NPI: 1679523088 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mansoor from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mansoor? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mansoor

Dr. Shadan Mansoor is a hematology & oncology in Burleson, TX, with 19 years in practice. Based on federal Medicare data, Dr. Mansoor performed 108,742 Medicare services across 1,644 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mansoor received a total of $2,820 from 36 pharmaceutical and/or device companies across 102 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mansoor is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 5% volume in TX$ $2,820 industry payments

Medicare Practice Summary

Medicare Utilization ↗
108,742
Medicare services
Top 5% in TX for hematology & oncology
1,644
Unique beneficiaries
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~5,723 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Iron infusion (Injectafer)72,750$1$3
Anti-nausea injection (fosaprepitant)16,800$0$5
Epoetin alfa injection (Procrit) for anemia9,750$6$28
Dexamethasone injection (steroid)2,596$0$5
Anti-nausea injection (Aloxi/palonosetron)1,400$1$52
Office visit, established patient (30-39 min)725$96$275
Drug injection, under skin or into muscle529$11$60
Injection of additional new drug or substance into vein398$12$70
COVID-19 test, self-administered395$12$30
Administration of chemotherapy into vein, 1 hour or less330$102$412
Office visit, established patient, complex (40-54 min)307$140$350
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less265$23$100
Flow cytometry, additional marker256$19$125
Injection, zoledronic acid, 1 mg187$6$300
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less177$50$190
Hospital follow-up visit, moderate complexity169$62$175
Administration of additional new drug or substance into vein, 1 hour or less155$51$202
Injection, diphenhydramine hcl, up to 50 mg152$1$10
Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month142$47$160
Office visit, established patient (20-29 min)140$61$175
Hospital follow-up visit, high complexity138$91$250
Administration of chemotherapy into vein, each additional hour119$22$93
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg105$1$5
Ct scan of chest with contrast100$51$401
CT scan of abdomen and pelvis with contrast85$162$681
Comprehensive metabolic blood panel66$10$50
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour65$16$60
Nuclear medicine study from skull base to mid-thigh with ct scan53$1,152$4,069
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries46$106$450
New patient office visit, complex (60-74 min)36$166$500
Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month36$37$120
Initial hospital admission, high complexity34$131$500
CT scan of chest, without contrast32$44$300
Infusion into a vein for hydration, 31-60 minutes31$25$155
New patient office visit (45-59 min)27$124$400
Infusion, normal saline solution , 1000 cc26$2$20
Ct scan of abdomen and pelvis without contrast21$77$338
Advance care planning consultation, first 30 min21$65$250
Collection of blood sample from implanted device19$21$60
Ct scan of soft tissue of neck with contrast18$58$399
Initial hospital admission, moderate complexity17$101$350
Telephone medical discussion with physician, 21-30 minutes13$94$300
Flow cytometry technique for dna or cell analysis, first marker11$59$200
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
67.4% high complexity
30.0% medium
2.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$2,820
Total received (2018-2024)
Avg $403/year across 7 years
Bottom 47% in TX for hematology & oncology
36
Companies
102
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,796 (99.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$24 (0.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$688
2023
$727
2022
$185
2021
$160
2020
$323
2019
$333
2018
$404

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Celgene Corporation
$255
Janssen Biotech, Inc.
$230
Novartis Pharmaceuticals Corporation
$227
PFIZER INC.
$217
Astellas Pharma US Inc
$213
Amgen Inc.
$142
PUMA BIOTECHNOLOGY, INC.
$136
Puma Biotechnology, Inc.
$127
Gilead Sciences, Inc.
$123
Exelixis Inc.
$119
Blueprint Medicines Corporation
$119
Ipsen Biopharmaceuticals, Inc
$102
E.R. Squibb & Sons, L.L.C.
$86
GlaxoSmithKline, LLC.
$84
GENZYME CORPORATION
$71
AstraZeneca Pharmaceuticals LP
$55
Kite Pharma, Inc.
$50
Takeda Pharmaceuticals U.S.A., Inc.
$49
ABBVIE INC.
$41
Agios Pharmaceuticals, Inc.
$40
Tempus AI, Inc
$36
Genentech USA, Inc.
$35
Pharmacyclics LLC, An AbbVie Company
$26
BeiGene USA, Inc.
$25
Daiichi Sankyo Inc.
$24
AVEO Pharmaceuticals, Inc.
$22
MorphoSys, US Inc.
$21
Mirati Therapeutics, Inc.
$21
Boston Scientific Corporation
$19
Eisai Inc.
$18
Seagen Inc.
$17
SOBI, INC
$16
ARRAY BIOPHARMA INC
$15
Secura Bio, Inc.
$14
Incyte Corporation
$12
Acrotech Biopharma LLC
$12
Top 3 companies account for 25.2% of total payments
Associated products mentioned in payments ›
AYVAKIT · BELEODAQ · BLENREP · BOSULIF · BRUKINSA · CABLIVI · COPIKTRA · Cabometyx · DARZALEX · DOPTELET · ELIQUIS · ENHERTU · EPKINLY · Enhertu · Erleada · FOTIVDA · Fabhalta · IBRANCE · IMBRUVICA · IMFINZI · INLYTA · JADENU · JAKAFI · JEMPERLI · KISQALI · KRAZATI · LUMAKRAS · LYNPARZA · Lenvima · MONJUVI · NERLYNX · Nerlynx · Nplate · OJJAARA · OPDUALAG · Onivyde · PADCEV · PROMACTA · PYRUKYND · Pomalyst · REBLOZYL · RYDAPT · Resolution Clip · SARCLISA · SCEMBLIX · SUTENT · TASIGNA · TECENTRIQ · TECVAYLI · Tecentriq · Trodelvy · VENCLEXTA · XALKORI · XOSPATA · XTANDI · Xospata · Xtandi · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $3 per 100 Medicare services performed
Looking for a hematology & oncology in Burleson?
Compare hematology & oncologys in the Burleson area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncologys nearby

Geographic Context

Hematology & Oncologys within 10 mi
36
Per 100K population
19.1
County median income
$81,826
Nearest hospital
BAYLOR SCOTT AND WHITE EMERGENCY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Mansoor is a mixed practice specialist, with above-average Medicare volume (top 5% in TX), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Mansoor experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Mansoor performed 72,750 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mansoor receive payments from pharmaceutical companies?
Yes. Dr. Mansoor received a total of $2,820 from 36 companies across 102 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mansoor's costs compare to other hematology & oncologys in Burleson?
Dr. Mansoor's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mansoor) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →